MENU
+Compare
RNXT
Stock ticker: NASDAQ
AS OF
Jul 3 closing price
Price
$1.36
Change
+$0.06 (+4.62%)
Capitalization
49.74M

RNXT RenovoRx Forecast, Technical & Fundamental Analysis

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment... Show more

RNXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for RNXT with price predictions
Jul 03, 2025

RNXT in -5.80% downward trend, falling for three consecutive days on June 27, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where RNXT declined for three days, in of 224 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for RNXT moved out of overbought territory on June 09, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 21 similar instances where the indicator moved out of overbought territory. In of the 21 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on July 01, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on RNXT as a result. In of 71 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for RNXT turned negative on June 10, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at .

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The 50-day moving average for RNXT moved above the 200-day moving average on June 18, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RNXT advanced for three days, in of 174 cases, the price rose further within the following month. The odds of a continued upward trend are .

RNXT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 65 cases where RNXT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RNXT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.781) is normal, around the industry mean (16.648). P/E Ratio (0.000) is within average values for comparable stocks, (58.447). RNXT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.259). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (149.254) is also within normal values, averaging (268.529).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RNXT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
RNXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

RNXT is expected to report earnings to rise 6.25% to -8 cents per share on August 13

RenovoRx RNXT Stock Earnings Reports
Q2'25
Est.
$-0.09
Q1'25
Beat
by $0.01
Q4'24
Missed
by $0.01
Q3'24
Beat
by $0.02
Q2'24
Est.
$-0.10
The last earnings report on May 15 showed earnings per share of -7 cents, beating the estimate of -9 cents. With 93.33K shares outstanding, the current market capitalization sits at 49.74M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
4546 El Camino Real
Phone
+1 650 284-4433
Employees
8
Web
https://www.renovorx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTSO1.090.09
+9.00%
Cytosorbents Corp
TG9.300.10
+1.09%
Tredegar Corp
DDHRF2.06N/A
N/A
Dream Impact Trust
SOIEF24.75N/A
N/A
Stolt-Nielsen Ltd
MTLHY24.64N/A
N/A
Mitsubishi Chemical Group Corporation

RNXT and Stocks

Correlation & Price change

A.I.dvisor tells us that RNXT and TARA have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RNXT and TARA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNXT
1D Price
Change %
RNXT100%
+4.62%
TARA - RNXT
29%
Poorly correlated
+3.96%
DMAC - RNXT
27%
Poorly correlated
+5.32%
IMRX - RNXT
27%
Poorly correlated
-3.90%
VANI - RNXT
25%
Poorly correlated
-0.79%
LENZ - RNXT
24%
Poorly correlated
+5.07%
More